Mr. Camilo Villalba reports
BLUEBERRIES MEDICAL AND THE COLOMBIAN SOCIETY OF PEDIATRICS PARTNER TO HOST MEDICINAL CANNABIS SEMINAR IN BOGOTA
Blueberries Medical Corp. has partnered with The Colombian Society of Pediatrics to host a full-day educational seminar for medical practitioners and other industry participants on the therapeutic benefits of medicinal cannabis and current industry developments. This event is part of the company's continuing initiatives focused on the development of medical education programs for physicians and patients in Latin America.
The event will be held on Oct. 11, 2019, in Bogota and has been designed to educate pediatricians, pediatric residents, general practitioners, alternative medicine specialists, psychiatrists and other health professionals on the applications and benefits of medicinal cannabis.
"This is a great opportunity to educate the medical and scientific community on the ever-growing medicinal cannabis industry and further position our company and brand within this community," stated Eduardo Molinari, chief marketing officer of Blueberries.
Attendees will receive industry-leading insights from Blueberries' team of experts as well as other renowned industry professionals including the founders of The International Research Center on Cannabis and Mental Health (IRCCMH) in New York, Dr. Jahan Marcus and Dr. Jan Roberts, who is also the former chief scientist for Americans for Safe Access. IRCCMH is a leading research and academic organization in the cannabis sector with extensive experience in cannabis research and education, pharmacology, product formulation and the efficacy of cannabis-based treatments. Based in New York and aligned with the Silver School of Social Work at New York University, IRCCMH comprises renowned scientists, educators and clinicians, and was created to bridge a gap between research and clinical practice.
The seminar includes a full day of presentations, workshops, panel discussions and networking opportunities providing attendees a comprehensive overview of industry developments and related matters including:
The current cannabis legislation in Colombia;
The physiology of the endocannabinoid system and clinical pharmacology of the products that contain cannabinoids (natural and synthetic): guidelines for use, absorption, metabolism, dosage and excretion;
Candidates for the use of cannabis derived drugs;
Refractory epilepsy and other pathologies of interest;
Evidence in chronic pain management;
Clinical case studies and formulations.
About Blueberries Medical Corp.
Blueberries Medical is a Latin American licensed producer of naturally grown premium quality cannabis with its primary operations ideally located in the Bogota Savannah of central Colombia and operations currently being established in Argentina. The company is led by a specialized team with proprietary expertise in agriculture, genetics, extraction, medicine, pharmacology and marketing. Blueberries is fully licensed for the cultivation, production, domestic distribution and international export of cannabidiol- and tetrahydrocannabinol-based medical cannabis in Colombia. Blueberries' combination of leading scientific expertise, agricultural advantages and distribution arrangements has positioned the company to become a leading international supplier of naturally grown, processed and standardized medicinal-grade cannabis oil extracts and related products.
We seek Safe Harbor.
© 2019 Canjex Publishing Ltd. All rights reserved.